Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants 2nd Edition Rosen

Evaluation Resource for Rosen 2nd Edition – Pharmacotherapeutics Handbook for Advanced Practice Nurses and Physician Assistants by Lehne

1. ISBN-10

   0323554954
2. ISBN-13

   978-0323554954
3. Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants, 2nd Edition expands on the same groundwork of clearly specified, up-to-date, and clinically relevant material as the trusted Lehne undergraduate text, while focusing on the information that advanced practice nurses and Physician Assistants specifically require for secure and effective prescribing. Initial chapters introduce foundational material for new prescribers in the areas of prescriptive authority, logical drug selection, prescription writing, and promoting positive effects of drug therapy. Core drug sections concentrate on the medications that prescribers will predominantly encounter in clinical practice. Emphasis will be placed on pharmacotherapeutic decision-making, with Black Box Warnings and new bulleted Key Prescribing Considerations features. The second edition includes entirely new chapters on Genetic and Genomic Considerations, Muscarinic Antagonists and Immunomodulators, and updated content throughout. It serves as a comprehensive resource for advanced practice nursing and Physician Assistant students to ensure safe and efficient prescribing!
   • Initial chapters tailored to the specific requirements of prescribers address topics such as prescriptive authority, logical drug selection, prescription writing, and promoting positive outcomes of drug therapy.
   • Carefully focused pharmacotherapeutic content reflects the medications commonly seen and utilized by prescribers, with focus not on the primary drug discovered or developed in each class but on the agents most frequently used at present. Primary care medications are discussed first in each chapter as appropriate, followed by acute care medications.
   • UNIQUE! Pedagogical aids targeted at prescribers further reinforce crucial information for prescribers.
   • Integrated coverage of Canadian brand names appears throughout the text and is highlighted with a recognizable maple-leaf icon.
   • Integrated coverage of interprofessional collaboration addresses the growing global interest in interprofessional collaboration and integrates opportunities for interprofessional collaborative practice throughout.
   • NEW! Genetic and Genomic Considerations chapter explores our increasing understanding of the importance of genetics and genomics in the pharmacotherapeutic management of disease.
   • NEW! Immunomodulators chapter covers the emerging role of this innovative therapy in cancer treatment.
   • NEW! Enhanced emphasis on the requirements of prescribers includes new Key Prescribing Considerations specifically tailored for advanced practice nurses (APNs) and Physician Assistants (PAs), revised introductory disease content, and updated illustrations.
   • NEW! Expanded delineation of acute care medications now extends to the cardiac, neurologic, hypertension, and male and female reproductive chapters.
   • NEW! Significantly revised content on laboratory drug monitoring now focuses on the requirements of APNs and PAs.
   • NEW! Updated content on drug regulations, opioid addiction, and legalized marijuana addresses these key areas of change for prescribers.
   • NEW! Illustrations, tables, and boxes have been incorporated instead of text to emphasize medication guidelines (including decision-making algorithms) and drug mechanisms of action.
   • NEW! Improved readability includes the removal of “small print” and a more user-friendly graphic design.
   • NEW! Updated content covers drug regulations, opioid addiction, marijuana.